Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis M Staudt

Showing results (201-210 of 286) with videos related to

Pageof 29
Sort By:
Cancer Research|March 15, 2024
NCI Cancer Research Data Commons: Resources to Share Key Cancer DataZhining Wang, Tanja M Davidsen, Gina R Kuffel, et al.
Blood|November 24, 2021
Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphomaTakashi Ishio, Sarvesh Kumar, Joji Shimono, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2006
BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphomaJaveed Iqbal, Vishala T Neppalli, George Wright, et al.
The Journal of Clinical Investigation|October 8, 2009
Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted modelsJames G Taylor, Adam T Cheuk, Patricia S Tsang, et al.
Nature|October 3, 2014
Loss of signalling via Gα13 in germinal centre B-cell-derived lymphomaJagan R Muppidi, Roland Schmitz, Jesse A Green, et al.
Blood|March 1, 2012
Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profilingKaren E Deffenbacher, Javeed Iqbal, Warren Sanger, et al.
Blood Advances|April 15, 2026
LySeqST: A targeted sequencing assay for robust genomic classification of diffuse large B-cell lymphomaLaura K Hilton, Sierra Gillis, Faraneh Yahyaei-Moayyed, et al.
Blood Advances|October 9, 2021
Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphomaChiara Pighi, Taek-Chin Cheong, Mara Compagno, et al.
International Journal of Cancer|June 12, 2013
Genome-wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological featuresAnna Enjuanes, Robert Albero, Guillem Clot, et al.
Human Pathology|August 6, 2014
BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphomaSamantha L Kendrick, Lucas Redd, Andrea Muranyi, et al.
Pageof 29

Showing results (201-210 of 286) with videos related to

Sort By:
Pageof 29
Cancer Research|March 15, 2024
NCI Cancer Research Data Commons: Resources to Share Key Cancer DataZhining Wang, Tanja M Davidsen, Gina R Kuffel, et al.
Blood|November 24, 2021
Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphomaTakashi Ishio, Sarvesh Kumar, Joji Shimono, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2006
BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphomaJaveed Iqbal, Vishala T Neppalli, George Wright, et al.
The Journal of Clinical Investigation|October 8, 2009
Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted modelsJames G Taylor, Adam T Cheuk, Patricia S Tsang, et al.
Nature|October 3, 2014
Loss of signalling via Gα13 in germinal centre B-cell-derived lymphomaJagan R Muppidi, Roland Schmitz, Jesse A Green, et al.
Blood|March 1, 2012
Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profilingKaren E Deffenbacher, Javeed Iqbal, Warren Sanger, et al.
Blood Advances|April 15, 2026
LySeqST: A targeted sequencing assay for robust genomic classification of diffuse large B-cell lymphomaLaura K Hilton, Sierra Gillis, Faraneh Yahyaei-Moayyed, et al.
Blood Advances|October 9, 2021
Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphomaChiara Pighi, Taek-Chin Cheong, Mara Compagno, et al.
International Journal of Cancer|June 12, 2013
Genome-wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological featuresAnna Enjuanes, Robert Albero, Guillem Clot, et al.
Human Pathology|August 6, 2014
BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphomaSamantha L Kendrick, Lucas Redd, Andrea Muranyi, et al.
Pageof 29